Effect of high-flow nasal therapy during exercise training in COPD patients with chronic respiratory failure: study protocol for a randomised controlled trial

被引:7
|
作者
Vitacca, Michele [1 ]
Pietta, Irene [2 ]
Lazzeri, Marta [3 ]
Paneroni, Mara [1 ]
机构
[1] Ist Clin Sci Maugeri IRCCS, Resp Rehabil Inst Lumezzane, Brescia, Italy
[2] ARIR Assoc, Milan, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
关键词
Rehabilitation; Exercise tolerance; Oxygen; Outcome; OBSTRUCTIVE PULMONARY-DISEASE; FIELD WALKING TESTS; GAS-EXCHANGE; REHABILITATION; EFFICACY; OXYGEN; INTENSITY; TOLERANCE; HYPEROXIA; DYSPNEA;
D O I
10.1186/s13063-019-3440-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundThe benefit of pulmonary rehabilitation (PR) in symptomatic chronic obstructive pulmonary disease (COPD) is well known. However, advanced patients with chronic respiratory failure (CRF), a category excluded from most studies, are frequently unable to sustain a work-load sufficiently high to obtain the full benefit of PR on exercise tolerance. Recent studies involving heated and humidified high flow oxygen therapy (HFOT) showed positive effects on breathing pattern and ventilatory efficiency during effort. We thus plan to compare, in COPD patients with CRF undergoing a high-intensity exercise programme, the effect of using HFOT versus standard oxygen delivery via Venturi Mask (V-mask), at the same inspiratory oxygen fraction, on improving exercise endurance.Methods/DesignThis is a multicentre randomised controlled trial that will involve 156 COPD inpatients with CRF recruited from seven PR hospitals. Patients will be randomised to one of two groups - V-mask versus HFOT. All patients will undergo the same high-intensity exercise programme using either of the oxygen delivery devices as per their group allocation. Training will consist of 20 sessions, over 1month (5 sessions per week) within the hospitalisation period. Anthropometric and clinical data, including body mass index, diagnosis, spirometry and comorbidities (Cumulative Rating Scale) will be collected at baseline. At baseline and at the end of the exercise programme (primary assessment time) evaluation will include exercise tolerance (Constant Work Rate Exercise Test) (primary outcome), functional capacity (6-min walk test), maximal inspiratory pressure/maximal expiratory pressure, peripheral muscle strength (biceps and quadriceps) by manual dynamometer, respiratory exchanges (blood gases analysis), disability (Barthel Index and Barthel Dyspnoea Index), impact of disease (COPD Assessment test), and quality of life (Maugeri Respiratory Failure Scale-26). At the end of the training period, patient satisfaction will be evaluated.DiscussionThis study will add knowledge about the exercise response in advanced COPD with CRF and verify if an alternative tool, namely HFOT, can increase the benefit obtained from PR.Trial registrationClinicalTrials.gov ID NET03322787Registered: 6 November 2017
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Effect of high-flow nasal therapy during exercise training in COPD patients with chronic respiratory failure: study protocol for a randomised controlled trial
    Michele Vitacca
    Irene Pietta
    Marta Lazzeri
    Mara Paneroni
    Trials, 20
  • [2] High-flow nasal cannula therapy for acute hypercapnic respiratory failure: A randomised controlled trial
    Alnajada, Asem
    Akhtar, Adeel
    Pavlov, Ivan
    Blackwood, Bronagh
    Mobrad, Abdulmajeed
    Sovani, Milind
    Shyamsundar, Murali
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] High-Flow Oxygen Therapy (HFOT) during training in COPD with chronic respiratory failure (CRF): a multicentre randomized controlled trial
    Vitacca, Michele
    Paneroni, Mara
    Zampogna, Elisabetta
    Spanevello, Antonio
    Ceriana, Piero
    Carlucci, Annalisa
    Banfi, Paolo
    Pappacoda, Gabriele
    Trianni, Ludovico
    Brogneri, Antonio
    Belli, Stefano
    Paracchini, Elena
    Aliani, Maria
    Spinelli, Vito
    Gigliotti, Francesco
    Lanini, Barbara
    Lazzeri, Marta
    Clini, Enrico
    Ambrosino, Nicolino
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial
    Alnajada, Asem
    Blackwood, Bronagh
    Mobrad, Abdulmajeed
    Akhtar, Adeel
    Shyamsundar, Murali
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [5] Comparison of high flow nasal cannula oxygen and conventional oxygen therapy on ventilatory support duration during acute-on-chronic respiratory failure: study protocol of a multicentre, randomised, controlled trial. The "HIGH-FLOW ACRF' study
    Ricard, Jean-Damien
    Dib, Fadia
    Esposito-Farese, Marina
    Messika, Jonathan
    Girault, Christophe
    BMJ OPEN, 2018, 8 (09):
  • [6] Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial
    McKinstry, Steven
    Singer, Joseph
    Baarsma, Jan Pieter
    Weatherall, Mark
    Beasley, Richard
    Fingleton, James
    RESPIROLOGY, 2019, 24 (11) : 1081 - 1087
  • [7] Multicentre, randomised trial to investigate early nasal high-flow therapy in paediatric acute hypoxaemic respiratory failure: a protocol for a randomised controlled trial-a Paediatric Acute respiratory Intervention Study (PARIS 2)
    Franklin, Donna
    Shellshear, Deborah
    Babl, Franz E.
    Schlapbach, Luregn J.
    Oakley, Ed
    Borland, Meredith L.
    Hoeppner, Tobias
    George, Shane
    Craig, Simon
    Neutze, Jocelyn
    Williams, Amanda
    Acworth, Jason
    McCay, Hamish
    Wallace, Alex
    Mattes, Joerg
    Gangathimn, Vinay
    Wildman, Mark
    Fraser, John F.
    Moloney, Susan
    Gavranich, John
    Waugh, John
    Hobbins, Sue
    Fahy, Rose
    Grew, Simon
    Gannon, Brenda
    Gibbons, Kristen
    Dalziel, Stuart
    Schibler, Andreas
    BMJ OPEN, 2019, 9 (12):
  • [8] High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial
    Azoulay, Elie
    Lemiale, Virginie
    Mokart, Djamel
    Nseir, Saad
    Argaud, Laurent
    Pene, Frederic
    Kontar, Loay
    Bruneel, Fabrice
    Klouche, Kada
    Barbier, Francois
    Reignier, Jean
    Stoclin, Anabelle
    Louis, Guillaume
    Constantin, Jean-Michel
    Mayaux, Julien
    Wallet, Florent
    Kouatchet, Achille
    Peigne, Vincent
    Perez, Pierre
    Girault, Christophe
    Jaber, Samir
    Oziel, Johanna
    Nyunga, Martine
    Terzi, Nicolas
    Bouadma, Lila
    Lebert, Christine
    Lautrette, Alexandre
    Bige, Naike
    Raphalen, Jean-Herle
    Papazian, Laurent
    Rabbat, Antoine
    Darmon, Michael
    Chevret, Sylvie
    Demoule, Alexandre
    TRIALS, 2018, 19
  • [9] High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial
    Elie Azoulay
    Virginie Lemiale
    Djamel Mokart
    Saad Nseir
    Laurent Argaud
    Frédéric Pène
    Loay Kontar
    Fabrice Bruneel
    Kada Klouche
    François Barbier
    Jean Reignier
    Anabelle Stoclin
    Guillaume Louis
    Jean-Michel Constantin
    Julien Mayaux
    Florent Wallet
    Achille Kouatchet
    Vincent Peigne
    Pierre Perez
    Christophe Girault
    Samir Jaber
    Johanna Oziel
    Martine Nyunga
    Nicolas Terzi
    Lila Bouadma
    Christine Lebert
    Alexandre Lautrette
    Naike Bigé
    Jean-Herlé Raphalen
    Laurent Papazian
    Antoine Rabbat
    Michael Darmon
    Sylvie Chevret
    Alexandre Demoule
    Trials, 19
  • [10] Nasal high-flow oxygen therapy for COPD with hypercapnia Benefits of home high-flow nasal oxygen therapy in hypercapnic respiratory failure
    Gillissen, A.
    ZEITSCHRIFT FUR PNEUMOLOGIE, 2023, 20 (01): : 52 - 55